Has Intuitive Surgical (ISRG) Outpaced Other Medical Stocks This Year?
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has Intuitive Surgical (ISRG) been one of those stocks this year? Let's take a closer look at the stock's year-to-date performance to find out.
Intuitive Surgical is a member of the Medical sector. This group includes 840 individual stocks and currently holds a Zacks Sector Rank of #2. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.
The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. ISRG is currently sporting a Zacks Rank of #2 (Buy).
The Zacks Consensus Estimate for ISRG's full-year earnings has moved 2.25% higher within the past quarter. This is a sign of improving analyst sentiment and a positive earnings outlook trend.
Based on the most recent data, ISRG has returned 26.01% so far this year. At the same time, Medical stocks have lost an average of 5.81%. As we can see, Intuitive Surgical is performing better than its sector in the calendar year.
To break things down more, ISRG belongs to the Medical - Instruments industry, a group that includes 93 individual companies and currently sits at #63 in the Zacks Industry Rank. This group has gained an average of 4.17% so far this year, so ISRG is performing better in this area.
ISRG will likely be looking to continue its solid performance, so investors interested in Medical stocks should continue to pay close attention to the company.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Intuitive Surgical, Inc. (ISRG) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
